BioNTech Announces New CFO Appointment

BioNTech SE has officially announced the appointment of Ramon Zapata-Gomez as its new Chief Financial Officer, with the transition set to take effect on July 1, 2025. Zapata-Gomez, who currently holds the position of CFO at Novartis's global biomedical research unit, is set to bring a wealth of experience from his extensive career across North America, Europe, and Latin America.

Leadership and Vision for the Future

Helmut Jeggle, Chairman of the Supervisory Board, expressed confidence in Zapata-Gomez's capabilities, highlighting his deep finance expertise and leadership qualities. "His understanding of market dynamics and ability to lead teams will be invaluable to BioNTech," Jeggle remarked.

Zapata-Gomez shared his enthusiasm about joining BioNTech, stating, "I am eager to contribute to the company's mission of improving patients' lives through innovative healthcare solutions."